Quidel | QDEL - Loan Capital


Quidel reported $0 in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Agilent USD 3.05B 1000K Mar/2026
Avanos Medical USD 87.3M 3M Mar/2026
Becton, Dickinson and Co. USD 14.71B 2.21B Mar/2026
Bruker USD 1.66B 189.6M Mar/2026
Cerus USD 64.86M 22K Dec/2024
Charles River Laboratories USD 2.66B 526.77M Mar/2026
Danaher USD 17.56B 855M Mar/2026
Haemonetics USD 1.22B 299.58M Mar/2026
Illumina USD 1.49B 0 Mar/2026
IQVIA Holdings USD 13.99B 105M Mar/2026
Merit Medical Systems USD 735.16M 1.12M Mar/2026
Mettler Toledo International USD 2.16B 73.35M Mar/2026
Myriad Genetics USD 120.3M 400K Mar/2026
Neogen USD 793.3M 374K Dec/2025
OraSure Technologies USD 100K 17K Dec/2025
Pacific Biosciences Of California USD 645.38M 223K Dec/2025
Quidel USD 0 2.47B Mar/2026
Revvity USD 2.63B 836K Mar/2026
STAAR Surgical USD 42K 42K Dec/2023
Thermo Fisher Scientific USD 40.07B 4.22B Mar/2026
Waters USD 5.22B 3.81B Mar/2026